StockTipsArenaBeta

BUY Anthem Biosciences Limited — IDBI Capital

BUYAnthem Biosciences Limited
Anthem Biosciences share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))3 Nov 2026via IDBI Capital Research Calls Telegram

Entry₹852Stated
Target₹910
Total upside +6.81% (call closed)
Stop loss₹824-3.29% risk
Exit₹9105 Nov 2026, 9:20 am
Target hit+6.81%0.00%upside left
Follow IDBI Capital for new calls(29% target hit, 425 closed calls)Get alertsWatch ANTHEM for new buy/sell callsGet alertsSee 203 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 5 Nov 2026
1 supporting1 neutral0 opposing
Supports the BUY call (1)

Anthem Biosciences reported Q2 FY27 consolidated revenue of ₹5,940 million, EBITDA of ₹3,304 million, and PAT of ₹2,115 million, showing year-on-year growth in profitability and margins.

BSE · Company Update·3 Nov · yesterday

(opens in new tab)
Neutral / worth noting (1)

The company reported its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.

BSE · Board Meeting·3 Nov · yesterday

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Anthem Biosciences

All analyst calls on Anthem Biosciences

More from IDBI Capital

Every call and its outcome